Companies / Institutes

3B Pharmaceuticals GmbH

Magnusstraße 11, 12489 Berlin

+49 30 6392-4317
+49 30 6392-4316


Dr. Jan Michel


3B Pharmaceuticals GmbH is a privately held pharmaceutical R&D company based in Berlin, Germany. The company is dedicated to the development of peptide-based pharmaceutical and diagnostic products. 3B Pharmaceuticals is pursuing R&D projects in hemophilia and oncology (nuclear medicine).


Growing importance of nuclear medicine for the treatment of cancer
Debiopharm expands its radiopharmaceutical footprint with an exclusive in-licensing agreement of 3B Pharmaceutical’s targeted CAIX radiotherapy
Logos: Clovis, 3BP
New partners in cancer research
Clovis Oncology acquires rights to FAP-targeted radiopharmaceutical program from 3B Pharmaceuticals and to discovery program for three additional ...
Boehringer Ingelheim and 3B Pharmaceuticals sign drug discovery collaboration
Harnessing the structural plethora of peptides to discover novel therapeutics
Andreas Häger and Wiebke Kropp-Büttner, Vestaxx
The world belongs to those that wait
On the perseverance of entrepreneurs and scientists from Adlershof
3B Pharmaceuticals, Biotech, Life Science Berlin
Partners in the fight against cancer
Ipsen enters into a licensing agreement with 3B Pharmaceuticals to develop novel radiopharmaceuticals in oncology